← back to search

Kai Zhao

Qingdao University ·
Area of research
Cancer Research · Genetics
Research interest
Research interests include Glioma Diagnosis and Treatment, Cancer-related molecular mechanisms research, MicroRNA in disease regulation, and Radiomics and Machine Learning in Medical Imaging.
h-index
27
citations
2,137
works
158
NIH funding
primary concept
email

Recent publications

Hypoxia-related and immune phenotype-related fusion model for non-invasive prognostication of hepatocellular carcinoma treated by TACE: a multicentre study
Gut 2026cited by 1position: middledoi
Comprehensive genome editing and signaling pathway engineering evolve potent and safe adenoviral producer cell
Communications Biology 2026cited by 0position: lastdoi
Unraveling temporal and spatial biomarkers of epithelial-mesenchymal transition in colorectal cancer: insights into the crucial role of immunosuppressive cells
Journal of Translational Medicine 2023cited by 27position: middledoi
Proteometabolomics of initial and recurrent glioblastoma highlights an increased immune cell signature with altered lipid metabolism
Neuro-Oncology 2023cited by 11position: middledoi
Prediction of intraoperative cerebrospinal fluid leaks in endoscopic endonasal transsphenoidal pituitary surgery based on a deep neural network model trained with MRI images: a pilot study
Frontiers in Neuroscience 2023cited by 4position: middledoi
Proteolytically generated soluble Tweak Receptor Fn14 is a blood biomarker for γ‐secretase activity
EMBO Molecular Medicine 2022cited by 12position: middledoi
Collective analysis of the expression and prognosis for LEM-domain proteins in prostate cancer
World Journal of Surgical Oncology 2022cited by 8position: middledoi
Cancer Treatment Evolution from Traditional Methods to Stem Cells andGene Therapy
Current Gene Therapy 2021cited by 37position: lastdoi
High Expression MicroRNA-206 Inhibits the Growth of Tumor Cells in Human Malignant Fibrous Histiocytoma
Frontiers in Cell and Developmental Biology 2021cited by 3position: middledoi
miR‑21/PTEN pathway mediates the cardioprotection of geniposide against oxidized low‑density�lipoprotein‑induced endothelial injury via suppressing oxidative stress and inflammatory response
International Journal of Molecular Medicine 2020cited by 33position: middledoi
IRGM promotes the PINK1‐mediated mitophagy through the degradation of Mitofilin in SH‐SY5Y cells
The FASEB Journal 2020cited by 18position: middledoi
YB-1 modulates the drug resistance of glioma cells by activation of MDM2/p53 pathway
Drug Design Development and Therapy 2019cited by 39position: middledoi
Mesenchymal glioblastoma constitutes a major ceRNA signature in the TGF-β pathway
Theranostics 2018cited by 69position: middledoi
Metabolomic Profiling of Human Spermatozoa in Idiopathic Asthenozoospermia Patients Using Gas Chromatography-Mass Spectrometry
BioMed Research International 2018cited by 63position: firstdoi
Combination of mild therapeutic hypothermia and adipose-derived stem cells for ischemic brain injury
Neural Regeneration Research 2018cited by 18position: middledoi
miR-30a suppresses osteosarcoma proliferation and metastasis by downregulating MEF2D expression
OncoTargets and Therapy 2018cited by 16position: middledoi
AMD3100 inhibits the migration and differentiation of neural stem cells after spinal cord injury
Scientific Reports 2017cited by 26position: middledoi
Intravenous Administration of Adipose-Derived Stem Cell Protein Extracts Improves Neurological Deficits in a Rat Model of Stroke
Stem Cells International 2017cited by 18position: firstdoi
Octreotide Ameliorates Renal Ischemia/Reperfusion Injury via Antioxidation and Anti-inflammation
Transplantation Proceedings 2017cited by 16position: middledoi
Wogonin inhibits LPS-induced tumor angiogenesis via suppressing PI3K/Akt/NF-κB signaling
European Journal of Pharmacology 2014cited by 57position: firstdoi
In-vitro metabolism of glycyrrhetinic acid by human and rat liver microsomes and its interactions with six CYP substrates
Journal of Pharmacy and Pharmacology 2012cited by 47position: firstdoi

Grants

Collaborative Research: Frameworks: FZ: A fine-tunable cyberinfrastructure framework to streamline specialized lossy compression development
NSF2344717$540,0002023–2027PIRePORTER
Collaborative Research: Frameworks: FZ: A fine-tunable cyberinfrastructure framework to streamline specialized lossy compression development
NSF2311877$540,0002023–2023PIRePORTER

Frequent collaborators

Wanping Zhang · Ministry of Education of the People's Republic of China3 papers (2017–2020)Linlu Tian · Medical College of Wisconsin3 papers (2017–2020)Xize Guo · Harbin Medical University3 papers (2017–2020)Rui Li · Fujian University of Traditional Chinese Medicine3 papers (2017–2020)Hongwei Xu · The First Affiliated Hospital, Sun Yat-sen University2 papers (2017–2020)Lixian Li · Harbin Medical University2 papers (2017–2020)Changcong Gu · Harbin Medical University2 papers (2017–2018) · 2 papers (2017–2020)Chun Wang · Harbin Medical University2 papers (2018–2020)Liu-Xue Du · Nanchang University2 papers (2017–2018)Long Liu · Binzhou Medical University2 papers (2017–2018)Yulong Jia · Harbin Medical University2 papers (2017–2018)Dejian Li · Fudan University1 papers (2021–2021)Yujie Huang · Nanjing University of Chinese Medicine1 papers (2014–2014)Dong Yang · Nanchang University1 papers (2018–2018)Boyuan Li · Tianjin University1 papers (2023–2023)Mingzhe Li · Ningbo University1 papers (2023–2023)Yan Zhang · Chongqing Three Gorges Academy of Agricultural Sciences1 papers (2021–2021)Bo Liang · Union Hospital1 papers (2026–2026)Yu Li · Guangzhou University of Chinese Medicine1 papers (2020–2020)